Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fasudil in ALS
NCT01935518Phase 2Unknown
- Sponsor
- Peking University Third Hospital
- Start
- Sep 2013
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fasudil in amyotrophic lateral sclerosis (ALS), sponsored by Peking University Third Hospital. Status: unknown.
02
Drugs
fasudil
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NCT01935518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01935518.